Virological breakthrough after immune checkpoint inhibitor and nucleos(t)ide analog treatment in patients with hepatitis B surface antigen positive hepatocellular carcinoma: a real-world study

• Li Liu,
• Yun Zhu,
• Yabing Guo,
• Ying Xia,
• Kunyuan Wang,
• Wenxuan Yu

Affiliations

Li Liu

Department of Neurology, Xuanwu hospital,Capital Medical University, Beijing, People`s Republic of China

Yun Zhu

School of Public Health, Tianjin Medical University, Wuqing District, Tianjin, China

Yabing Guo

Aff3 grid.416466.7Department of Infectious Diseases and Hepatology UnitNanfang Hospital Peoples Republic of China

Ying Xia

Medtronic Inc, Minneapolis, Minnesota, USA

Kunyuan Wang

State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China

Wenxuan Yu

State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China